Journal of Oral Pathology and Medicine · 2019 · 599 citations · 20 references
DentistryOral BiologyOral MedicineMetabolomicsOral DiagnosisOral OncologyCancer MetabolomicsMalignant Oral TumorsOral Cancer BiomarkersOral Cancer PrognosisOral Disease DiagnosticsSalivary MetabolomicsLiquid Chromatography-mass SpectrometryLiquid Chromatography-mass Spectrometry AnalysisMaldi-tof Mass SpectrometrySalivary Biomarker AnalysisSalivary Cancer Biomarker TestingSalivary Cancer BiomarkersSalivary Metabolite DetectionTumor-specific Biomarkers
Metabolomics analyzes the full repertoire of small molecules, and salivary metabolomics may identify tumor‑specific biomarkers for early diagnosis and predicting tumor progression. The study aims to evaluate the clinical utility of salivary metabolites for detecting oral leukoplakia and OSCC and for preventing malignant transformation and improving prognosis. Salivary metabolomic profiles of 21 leukoplakia, 22 OSCC, and 18 controls were analyzed by Q‑TOF LC‑MS, with metabolites identified using MassHunter and Metlin, and statistical comparisons performed by ANOVA, t‑tests, and chi‑square. Significant upregulation of metabolites such as 1‑methylhistidine, inositol 1,3,4‑triphosphate, d‑glycerate‑2‑phosphate, 4‑nitroquinoline‑1‑oxide, 2‑oxoarginine, norcocaine nitroxide, sphinganine‑1‑phosphate, and pseudouridine, and downregulation of l‑homocysteic acid, ubiquinone, neuraminic acid, and estradiol valerate were observed, indicating distinct salivary metabolic signatures in oral leukoplakia and OSCC.
Metabolomics is the study of metabolome which describes the full repertoire of small molecules, and the analysis of salivary metabolomics may help in identifying tumor-specific biomarkers for early diagnosis and prediction of tumor progression. The aim of the study was to evaluate the clinical utility of salivary metabolites in oral leukoplakia and oral squamous cell carcinoma.Salivary metabolomic profile of patients diagnosed with oral leukoplakia (n = 21) and oral squamous cell carcinoma (n = 22) was compared with apparently normal controls (n = 18) using Q-TOF-liquid chromatography-mass spectrometry. MassHunter profile software and Metlin database were used for metabolite identification. ANOVA to identify the regulation of metabolites between the three groups, t test (P < 0.05) to signify the changes between two groups, and chi-square test (P < 0.05) to indicate the presence or absence of metabolites in the study participants of the three groups were performed.Significant upregulation of 1-methylhistidine, inositol 1,3,4-triphosphate, d-glycerate-2-phosphate, 4-nitroquinoline-1-oxide, 2-oxoarginine, norcocaine nitroxide, sphinganine-1-phosphate, and pseudouridine in oral leukoplakia and OSCC was noted. Downregulated compounds in the diseased groups included l-homocysteic acid, ubiquinone, neuraminic acid, and estradiol valerate.A range of salivary metabolites were significantly altered in oral leukoplakia and oral squamous cell carcinoma. Further, it is necessary to evaluate the clinical utility of the individual metabolites in preventing malignant transformation of oral leukoplakia and to improve prognosis of oral squamous cell carcinoma.
20
Salivary metabolite signatures of oral cancer and leukoplakia
Jie Wei, Guoxiang Xie, Zengtong Zhou et al. · International Journal of Cancer · 2010 · 245 citations · Full text
Identification of salivary metabolomic biomarkers for oral cancer screening
Shigeo Ishikawa, Masahiro Sugimoto, Kenichiro Kitabatake et al. · Scientific Reports · 2016 · 205 citations · Full text
Dentistry, Oncology, Oral Biology +17